StockComparison Logo
vs

GSK vs ACN

Comparison between GSK Plc (GSK, Company) and Accenture plc - Class A (ACN, Company).

GSK is from the Healthcare sector, while ACN is from the Technology sector.

5-Year PerformanceGSK has outperformed ACN, delivering a return of +4.9% compared to -10.2%

GSK vs ACN - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
GSK
$105B
ACN
$104B
Max Drawdown
Winner
GSK
64.03%
ACN
70.04%
Sharpe Ratio
Winner
GSK
1.40
ACN
-0.64
5Y Beta
Winner
GSK
0.24
ACN
0.60
Industry
GSK
Drug Manufacturers - General
ACN
Information Technology Services
P/E Ratio
GSK
16.34
Winner
ACN
12.30
Forward P/E
GSK
20.79
Winner
ACN
11.21
PEG Ratio
Winner
GSK
0.37
ACN
0.92
Dividend Yield
GSK
3.53%
Winner
ACN
3.83%
5Y Dividends CAGR
GSK
1.92%
Winner
ACN
18.39%
5Y EPS CAGR
GSK
1.36%
Winner
ACN
12.06%
Debt to Equity
GSK
103.36%
Winner
ACN
0.35%
Free Cash Flow Yield
GSK
8.93%
Winner
ACN
12.05%
P/S Ratio
GSK
3.10
Winner
ACN
1.43
P/B Ratio
GSK
4.33
Winner
ACN
3.18

GSK vs ACN - Historical Returns

Returns include dividend reinvestment.

1M
GSK
-1.73%
Winner
ACN
+26.41%
3M
Winner
GSK
+4.20%
ACN
-0.82%
6M
Winner
GSK
-11.86%
ACN
-27.42%
1Y
Winner
GSK
+47.31%
ACN
-28.55%
5Y(CAGR)
Winner
GSK
+4.89%
ACN
-10.17%
10Y(CAGR)
GSK
+4.01%
Winner
ACN
+6.00%
Max(CAGR)
GSK
+3.16%
Winner
ACN
+11.95%

GSK vs ACN - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearGSKACN
2026+6.96%-32.42%
2025+50.62%-21.43%
2024-6.27%+3.04%
2023+9.25%+31.88%
2022-32.73%-33.58%
2021+23.62%+63.63%
2020-17.52%+26.31%
2019+30.36%+51.66%
2018+9.29%-6.67%
2017-3.80%+34.11%
2016+1.52%+17.33%
2015+0.48%+20.17%
2014-14.73%+12.88%
2013+26.97%+21.90%
2012-0.75%+28.40%
2011+22.51%+11.72%
2010-3.72%+17.42%
2009+20.27%+25.61%
2008-21.93%-6.23%
2007-2.77%+0.03%
2006+6.93%+27.42%
2005+9.96%+10.79%
2004+5.08%+4.17%
2003+25.04%+41.43%
2002-22.83%-31.36%
2001-9.58%+77.46%
2000+5.67%N/A
1999-5.78%N/A

GSK vs ACN Drawdown Comparison

The maximum drawdown for GSK was -50.11%, occurring on Sep 27, 2022. Recovery took 935 trading sessions.

The maximum drawdown for ACN was -67.75%, occurring on Jun 30, 2026. This drawdown has not yet recovered.

The current GSK drawdown is -13.23%. The current ACN drawdown is -55.13%.

RankGSKACN
#1-50.11%
Apr 13, 2022 - Jan 6, 2026
-67.75%
Feb 5, 2025 - Jun 30, 2026
#2-49.64%
Apr 20, 2007 - Apr 18, 2012
-59.20%
Mar 11, 2002 - Jan 5, 2006
#3-45.23%
Apr 25, 2000 - Nov 11, 2005
-39.69%
Dec 29, 2021 - Feb 5, 2025
#4-32.56%
Jan 17, 2020 - Dec 10, 2021
-36.59%
Jul 23, 2007 - Dec 1, 2009
#5-27.97%
Mar 4, 2014 - Sep 3, 2019
-33.45%
Feb 19, 2020 - Jun 25, 2020
#6-26.98%
Nov 5, 1999 - Apr 11, 2000
-25.22%
Jul 7, 2011 - Mar 15, 2012
#7-18.51%
Feb 18, 2026 - Jun 2, 2026
-23.55%
Aug 1, 2001 - Oct 12, 2001
#8-14.45%
Jan 18, 2022 - Apr 7, 2022
-22.56%
Sep 21, 2018 - Mar 28, 2019
#9-10.52%
May 16, 2006 - Feb 13, 2007
-21.74%
Feb 27, 2006 - Oct 26, 2006
#10-10.48%
Oct 4, 2012 - Mar 22, 2013
-18.42%
Apr 23, 2010 - Oct 5, 2010
#11-8.45%
May 28, 2013 - Nov 1, 2013
-15.21%
Mar 26, 2012 - Sep 13, 2012
#12-8.43%
Apr 11, 2000 - Apr 25, 2000
-14.95%
Oct 28, 2015 - Mar 24, 2016
#13-8.16%
Nov 11, 2005 - Mar 8, 2006
-14.44%
May 28, 2013 - Dec 26, 2013
#14-7.54%
Feb 14, 2007 - Apr 16, 2007
-14.16%
Jan 10, 2002 - Feb 1, 2002
#15-7.37%
Jan 21, 2014 - Feb 13, 2014
-13.25%
Sep 2, 2020 - Nov 24, 2020

Correlation

Correlation between GSK and ACN is 0.73 which considered as a strong positive correlation - the stocks tend to move together.

0.73
-101

Dividend Comparison (2000 - 2026)

GSK vs ACN dividend yield comparison.

YearGSKACN
20261.81%2.86%
20253.42%2.26%
20244.60%1.52%
20233.75%1.33%
20225.47%1.51%
20214.99%0.87%
20205.59%1.26%
20194.35%1.07%
20185.65%1.98%
20175.83%1.66%
20166.86%1.97%
20155.93%2.03%
20146.20%2.18%
20134.51%2.12%
20125.70%2.23%
20114.83%2.11%
20105.10%1.70%
20094.39%1.81%
20085.74%3.05%
20074.09%1.17%
20063.29%0.95%
20053.03%1.04%
20043.38%0.00%
20032.77%0.00%
20023.10%0.00%
20011.54%0.00%
20004.57%0.00%

Select Stocks to Compare